FR2730637B1
(fr)
|
1995-02-17 |
1997-03-28 |
Rhone Poulenc Rorer Sa |
Composition pharmaceutique contenant des acides nucleiques, et ses utilisations
|
CA2222328C
(en)
*
|
1995-06-07 |
2012-01-10 |
Inex Pharmaceuticals Corporation |
Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
|
US7422902B1
(en)
|
1995-06-07 |
2008-09-09 |
The University Of British Columbia |
Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
|
FR2739292B1
(fr)
*
|
1995-09-28 |
1997-10-31 |
Rhone Poulenc Rorer Sa |
Composition pharmaceutique utile pour la transfection d'acides nucleiques et ses utilisations
|
GB2324534B
(en)
*
|
1996-01-06 |
2000-05-10 |
Danbiosyst Uk |
Composition for delivery of nucleic acid to a cell
|
EP0934082B1
(de)
*
|
1996-10-23 |
2002-07-17 |
SKW Trostberg Aktiengesellschaft |
Verfahren zur herstellung von biologisch aktiven polymernanopartikel-nucleinsäure-konjugaten
|
AU729655B2
(en)
*
|
1996-11-12 |
2001-02-08 |
Regents Of The University Of California, The |
Preparation of stable formulations of lipid-nucleic acid complexes for efficient in vivo delivery
|
US6884430B1
(en)
*
|
1997-02-10 |
2005-04-26 |
Aventis Pharma S.A. |
Formulation of stabilized cationic transfection agent(s) /nucleic acid particles
|
DE69841648D1
(de)
*
|
1997-03-11 |
2010-06-17 |
Univ Minnesota |
Dns-basiertes transposon-system für die einführung von nucleinsäure in die dns einer zelle
|
US5912225A
(en)
|
1997-04-14 |
1999-06-15 |
Johns Hopkins Univ. School Of Medicine |
Biodegradable poly (phosphoester-co-desaminotyrosyl L-tyrosine ester) compounds, compositions, articles and methods for making and using the same
|
US6524613B1
(en)
|
1997-04-30 |
2003-02-25 |
Regents Of The University Of Minnesota |
Hepatocellular chimeraplasty
|
DE19726186A1
(de)
*
|
1997-06-20 |
1998-12-24 |
Boehringer Ingelheim Int |
Komplexe für den Transport von Nukleinsäure in höhere eukaryotische Zellen
|
US20020022034A1
(en)
*
|
1997-09-15 |
2002-02-21 |
Julianna Lisziewicz |
Therapeutic DNA vaccination
|
ES2279580T3
(es)
*
|
1997-09-15 |
2007-08-16 |
Genetic Immunity, Llc |
Composiciones para administrar genes a celulas de la piel que presentan antigenos.
|
DE19743135A1
(de)
*
|
1997-09-30 |
1999-04-01 |
Hoechst Marion Roussel De Gmbh |
Biologisch verträgliche niedermolekular Polyethylenimine
|
CA2335460A1
(en)
*
|
1998-06-18 |
1999-12-23 |
Johns Hopkins University School Of Medicine |
Polymers for delivery of nucleic acids
|
US6916490B1
(en)
|
1998-07-23 |
2005-07-12 |
UAB Research Center |
Controlled release of bioactive substances
|
EP1044679B1
(de)
*
|
1998-11-02 |
2012-12-26 |
Terumo Kabushiki Kaisha |
Stabile Liposomen für Gezielte Arzneimittlelgabe
|
US7160682B2
(en)
*
|
1998-11-13 |
2007-01-09 |
Regents Of The University Of Minnesota |
Nucleic acid transfer vector for the introduction of nucleic acid into the DNA of a cell
|
CN1354678A
(zh)
*
|
1999-04-02 |
2002-06-19 |
研究发展基金会 |
用于气溶胶传递的聚乙烯亚胺:dna制剂
|
US6770740B1
(en)
|
1999-07-13 |
2004-08-03 |
The Regents Of The University Of Michigan |
Crosslinked DNA condensate compositions and gene delivery methods
|
FR2797402B1
(fr)
|
1999-07-15 |
2004-03-12 |
Biomerieux Stelhys |
Utilisation d'un polypeptide pour detecter, prevenir ou traiter un etat pathologique associe a une maladie degenerative, neurologique ou autoimmune
|
DE19960206A1
(de)
*
|
1999-12-14 |
2001-07-19 |
Frank Czubayko |
Komplexierung von RNS mit Polyethyleniminen zur deren Stabilisierung und zellulären Einschleusung
|
AU782912B2
(en)
|
1999-12-28 |
2005-09-08 |
Association Francaise Contre Les Myopathies |
Use of lithium (Li+) for the preparation of a composition for transfection of a polynucleotide into a cell and compositions useful in gene therapy
|
CN101041079A
(zh)
*
|
1999-12-30 |
2007-09-26 |
诺瓦提斯公司 |
用于基因治疗的新的胶体合成载体
|
FR2805271B1
(fr)
*
|
2000-02-18 |
2002-04-26 |
Aventis Pharma Sa |
Procede de preparation de polyalkylenimines fonctionnalises, compositions les contenant et leurs utilisations
|
AU2001287801A1
(en)
*
|
2000-09-05 |
2002-03-22 |
Gencell S.A. |
Acid-sensitive compounds, preparation and uses thereof
|
FR2813605B1
(fr)
*
|
2000-09-05 |
2002-10-18 |
Aventis Pharma Sa |
Composes acidosensibles, leur preparation et utilisations
|
FR2814370B1
(fr)
*
|
2000-09-22 |
2004-08-20 |
Centre Nat Rech Scient |
Utilisation d'un complexe acide nucleique/pei pour le ciblage de cellules souches du cerveau
|
US20040048819A1
(en)
*
|
2000-10-09 |
2004-03-11 |
Joachim Simon |
Complexes for transferring nucleic acids into cells
|
DE10145134A1
(de)
*
|
2000-10-09 |
2002-05-16 |
Bayer Ag |
Komplexe zur Einführung von Nukleinsäuren in Zellen
|
US20020091242A1
(en)
|
2000-10-11 |
2002-07-11 |
Michel Bessodes |
Acid-sensitive compounds, their preparation and uses
|
CA2437555A1
(en)
*
|
2001-02-01 |
2002-08-08 |
Yiyu Zou |
Stabilised polymeric aerosols for pulmonary gene delivery
|
US6652886B2
(en)
|
2001-02-16 |
2003-11-25 |
Expression Genetics |
Biodegradable cationic copolymers of poly (alkylenimine) and poly (ethylene glycol) for the delivery of bioactive agents
|
US20040234586A1
(en)
*
|
2001-06-11 |
2004-11-25 |
Sylvain Meloche |
Compositions and methods for enhancing nucleic acid transfer into cells
|
CA2492826C
(en)
|
2001-09-14 |
2016-12-13 |
Cytos Biotechnology Ag |
Encapsulation of unmethylated cpg-containing oligonucleotides into virus-like particles: method of preparation and use
|
JP2005508396A
(ja)
*
|
2001-11-02 |
2005-03-31 |
イントラディグム、コーポレイション |
核酸送達ビヒクルのための治療方法
|
ATE350638T1
(de)
|
2002-01-17 |
2007-01-15 |
York Refrigeration Aps |
Getauchter verdampfer mit integriertem wärmeaustauscher
|
AU2003231048A1
(en)
*
|
2002-04-22 |
2003-11-03 |
Regents Of The University Of Minnesota |
Transposon system and methods of use
|
WO2003099225A2
(en)
|
2002-05-24 |
2003-12-04 |
Mirus Corporation |
Compositions for delivering nucleic acids to cells
|
WO2004002453A1
(en)
|
2002-06-28 |
2004-01-08 |
Protiva Biotherapeutics Ltd. |
Method and apparatus for producing liposomes
|
US20050196382A1
(en)
*
|
2002-09-13 |
2005-09-08 |
Replicor, Inc. |
Antiviral oligonucleotides targeting viral families
|
WO2004024919A1
(en)
*
|
2002-09-13 |
2004-03-25 |
Replicor, Inc. |
Non-sequence complementary antiviral oligonucleotides
|
EP1413874A1
(de)
|
2002-10-16 |
2004-04-28 |
Streck Laboratories, Inc. |
Verfahren und Vorrichtung zum Sammeln und Konservieren von Zellen für die Analyse
|
WO2004083450A2
(en)
*
|
2003-03-21 |
2004-09-30 |
The General Hospital Corporation D/B/A Massachusetts General Hospital |
Hyperbranched dendron and methods of synthesis and use thereof
|
EP1648519B1
(de)
|
2003-07-16 |
2014-10-08 |
Protiva Biotherapeutics Inc. |
Lipid verkapselte interferierende rns
|
NZ592917A
(en)
|
2003-09-15 |
2012-12-21 |
Protiva Biotherapeutics Inc |
Stable polyethyleneglycol (PEG) dialkyloxypropyl (DAA) lipid conjugates
|
US20060058255A1
(en)
*
|
2004-03-01 |
2006-03-16 |
Jianzhu Chen |
RNAi-based therapeutics for allergic rhinitis and asthma
|
EP1730286A4
(de)
*
|
2004-03-04 |
2007-09-05 |
Massachusetts Inst Technology |
Therapeutische antikrebs-dna
|
US20060026699A1
(en)
*
|
2004-06-04 |
2006-02-02 |
Largaespada David A |
Methods and compositions for identification of genomic sequences
|
US7745651B2
(en)
|
2004-06-07 |
2010-06-29 |
Protiva Biotherapeutics, Inc. |
Cationic lipids and methods of use
|
WO2005121348A1
(en)
|
2004-06-07 |
2005-12-22 |
Protiva Biotherapeutics, Inc. |
Lipid encapsulated interfering rna
|
EP1773857A4
(de)
|
2004-07-02 |
2009-05-13 |
Protiva Biotherapeutics Inc |
Das immunsystem stimulierende sirna-moleküle und anwendungen davon
|
CA2628300C
(en)
|
2005-11-02 |
2018-04-17 |
Protiva Biotherapeutics, Inc. |
Modified sirna molecules and uses thereof
|
US7915399B2
(en)
|
2006-06-09 |
2011-03-29 |
Protiva Biotherapeutics, Inc. |
Modified siRNA molecules and uses thereof
|
WO2009137911A1
(en)
*
|
2008-05-15 |
2009-11-19 |
National Research Counsil Of Canada |
Process, vectors and engineered cell lines for enhanced large-scale transfection
|
US20080312174A1
(en)
*
|
2007-06-05 |
2008-12-18 |
Nitto Denko Corporation |
Water soluble crosslinked polymers
|
TW200918099A
(en)
*
|
2007-09-14 |
2009-05-01 |
Nitto Denko Corp |
Drug carriers
|
EP2047858A1
(de)
|
2007-10-10 |
2009-04-15 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Kombinationsprodukte zur Krebsbehandlung
|
CN101918566A
(zh)
|
2007-11-22 |
2010-12-15 |
Biontex实验室有限公司 |
通过影响先天性免疫系统改进非病毒输送系统的转染结果
|
DE102008023913A1
(de)
|
2008-05-16 |
2009-11-19 |
Biontex Laboratories Gmbh |
Verbesserung von Transfektionsergebnissen nicht-viraler Genliefersysteme durch Beeinflussung des angeborenen Immunsystems
|
DE102008016275A1
(de)
|
2008-03-28 |
2009-11-19 |
Biontex Laboratories Gmbh |
Verbesserung von Transfektionsergebnissen nicht-viraler Genliefersysteme durch Blockierung des angeborenen Immunsystems
|
DE102007056488A1
(de)
|
2007-11-22 |
2009-07-23 |
Biontex Laboratories Gmbh |
Steigerung von Transfektionseffizienzen nicht-viraler Genliefersysteme durch Blockierung des angeborenen Immunsystems
|
GB0724253D0
(en)
|
2007-12-12 |
2008-01-30 |
Fermentas Uab |
Transfection reagent
|
ES2535419T3
(es)
|
2007-12-27 |
2015-05-11 |
Protiva Biotherapeutics Inc. |
Silenciamiento de expresión de quinasa tipo polo usando ARN interferente
|
US7687027B2
(en)
*
|
2008-02-27 |
2010-03-30 |
Becton, Dickinson And Company |
Cleaning compositions, methods and materials for reducing nucleic acid contamination
|
FR2928373B1
(fr)
*
|
2008-03-05 |
2010-12-31 |
Centre Nat Rech Scient |
Polymere derive de la polyethylenimine lineaire pour le transfert de gene.
|
PL2279254T3
(pl)
|
2008-04-15 |
2017-11-30 |
Protiva Biotherapeutics Inc. |
Nowe preparaty lipidowe do dostarczania kwasów nukleinowych
|
CA2721380A1
(en)
|
2008-04-15 |
2009-10-22 |
Protiva Biotherapeutics, Inc. |
Silencing of csn5 gene expression using interfering rna
|
CA2984026C
(en)
|
2008-10-09 |
2020-02-11 |
Arbutus Biopharma Corporation |
Improved amino lipids and methods for the delivery of nucleic acids
|
US20100167271A1
(en)
*
|
2008-12-30 |
2010-07-01 |
Streck, Inc. |
Method for screening blood using a preservative that may be in a substantially solid state form
|
US11634747B2
(en)
*
|
2009-01-21 |
2023-04-25 |
Streck Llc |
Preservation of fetal nucleic acids in maternal plasma
|
DE102009006606A1
(de)
|
2009-01-29 |
2010-08-05 |
Philipps-Universität Marburg |
Nicht-virales Transfektionsmittel
|
DK2398912T3
(en)
|
2009-02-18 |
2017-10-30 |
Streck Inc |
Conservation of cell-free nucleic acids
|
EP2623117A1
(de)
|
2009-04-30 |
2013-08-07 |
Genetic Immunity Kft. |
Immunogene Nanomedizinzusammensetzung sowie ihre Herstellung und Verwendung
|
US9018187B2
(en)
|
2009-07-01 |
2015-04-28 |
Protiva Biotherapeutics, Inc. |
Cationic lipids and methods for the delivery of therapeutic agents
|
IL292615B2
(en)
|
2009-07-01 |
2023-11-01 |
Protiva Biotherapeutics Inc |
Nucleic acid-lipid particles, preparations containing them and their uses
|
WO2011000106A1
(en)
|
2009-07-01 |
2011-01-06 |
Protiva Biotherapeutics, Inc. |
Improved cationic lipids and methods for the delivery of therapeutic agents
|
US9856456B2
(en)
*
|
2009-10-12 |
2018-01-02 |
Thermo Fisher Scientific Baltics Uab |
Delivery agent
|
EP2488210A4
(de)
|
2009-10-12 |
2014-04-30 |
Smith Holdings Llc |
Verfahren und zusammensetzungen zur modulation der genexpression mit in-vivo oder in-vitro verabreichten arzneistoffen auf oligonukleotidbasis
|
GB0917792D0
(en)
*
|
2009-10-12 |
2009-11-25 |
Fermentas Uab |
Delivery agent
|
CA2780536C
(en)
*
|
2009-11-09 |
2018-01-02 |
Streck, Inc. |
Stabilization of rna in and extracting from intact cells within a blood sample
|
EP2549859B1
(de)
|
2010-03-24 |
2017-06-21 |
Institut National de la Santé et de la Recherche Medicale |
Mit einem Hepatitis-B-Virus aus menschlischem Gentotyp Primatenmodell der Familie der Cercopithecidae
|
WO2011120953A1
(en)
|
2010-03-29 |
2011-10-06 |
Universite De Strasbourg |
Polymers for delivering molecules of interest
|
EP2582387A2
(de)
|
2010-06-17 |
2013-04-24 |
The United States Of America As Represented By The Secretary, National Institutes Of Health |
Zusammensetzungen und verfahren zur behandlung von entzündungserkrankungen
|
AU2011269041B2
(en)
|
2010-06-22 |
2015-05-07 |
Centre National De La Recherche Scientifique |
Optimized in vivo delivery system with endosomolytic agents for nucleic acid conjugates
|
WO2012000104A1
(en)
|
2010-06-30 |
2012-01-05 |
Protiva Biotherapeutics, Inc. |
Non-liposomal systems for nucleic acid delivery
|
EP2704740B1
(de)
|
2011-05-04 |
2016-10-05 |
Streck, Inc. |
Inaktiviertes schweinegrippe-virus und verfahren zu seiner herstellung
|
WO2013040552A2
(en)
|
2011-09-16 |
2013-03-21 |
Georgia Health Sciences University |
Methods of promoting immune tolerance
|
WO2013075132A1
(en)
|
2011-11-17 |
2013-05-23 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Therapeutic rna switches compositions and methods of use
|
EP2782997B1
(de)
|
2011-11-24 |
2018-01-10 |
Genethon |
Mit industriellen pharmazeutischen anwendungen kompatibles skalierbares lentivirusvektor-produktionssystem
|
US9035039B2
(en)
|
2011-12-22 |
2015-05-19 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for silencing SMAD4
|
KR20150020288A
(ko)
*
|
2012-06-08 |
2015-02-25 |
에트리스 게엠베하 |
메신저 rna의 폐전달
|
CN103059295B
(zh)
*
|
2012-09-26 |
2016-01-13 |
上海交通大学 |
疏水修饰的聚乙烯亚胺及其作为蛋白质载体的用途
|
DK2903652T3
(da)
|
2012-10-05 |
2022-07-04 |
Biontech Delivery Tech Gmbh |
Hydroxylerede polyaminderivater som transfektionsreagenser
|
HUE058785T2
(hu)
|
2012-10-08 |
2022-09-28 |
Biontech Delivery Tech Gmbh |
Karboxilált poliamin-származékok, mint transzfekciós reagensek
|
DE102012111891A1
(de)
*
|
2012-12-06 |
2014-06-12 |
Eberhard Karls Universität Tübingen Medizinische Fakultät |
Verbesserung der Zielfindungskapazität von Stammzellen
|
CA2917912C
(en)
|
2013-07-24 |
2019-09-17 |
Streck, Inc. |
Compositions and methods for stabilizing circulating tumor cells
|
EP3068891A1
(de)
|
2013-11-13 |
2016-09-21 |
Aequus Biopharma Inc. |
Manipulierte glycoproteine und verwendungen davon
|
WO2016054421A1
(en)
|
2014-10-02 |
2016-04-07 |
Protiva Biotherapeutics, Inc |
Compositions and methods for silencing hepatitis b virus gene expression
|
EP3034539A1
(de)
|
2014-12-19 |
2016-06-22 |
Ethris GmbH |
Zusammensetzungen zur Einführung von Nukleinsäure in Zellen
|
US11168351B2
(en)
|
2015-03-05 |
2021-11-09 |
Streck, Inc. |
Stabilization of nucleic acids in urine
|
CA2984879A1
(en)
|
2015-05-05 |
2016-11-10 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd |
Nucleic acid-cationic polymer compositions and methods of making and using the same
|
WO2016197132A1
(en)
|
2015-06-04 |
2016-12-08 |
Protiva Biotherapeutics Inc. |
Treating hepatitis b virus infection using crispr
|
EP3329003A2
(de)
|
2015-07-29 |
2018-06-06 |
Arbutus Biopharma Corporation |
Zusammensetzungen und verfahren zur ausschaltung einer hepatitis-b-virus-genexpression
|
US20170145475A1
(en)
|
2015-11-20 |
2017-05-25 |
Streck, Inc. |
Single spin process for blood plasma separation and plasma composition including preservative
|
US10010627B2
(en)
|
2016-06-03 |
2018-07-03 |
International Business Machines Corporation |
Modified polycationic polymers
|
EP3491381A1
(de)
|
2016-07-29 |
2019-06-05 |
Streck, Inc. |
Suspensionszusammensetzung zur kontrolle einer hämatologischen analyse
|
CN110418650A
(zh)
|
2016-11-16 |
2019-11-05 |
免疫治疗有限公司 |
用于治疗过敏的核酸
|
WO2018134310A1
(en)
|
2017-01-19 |
2018-07-26 |
Universiteit Gent |
Molecular adjuvants for enhanced cytosolic delivery of active agents
|
CN110799529A
(zh)
|
2017-04-22 |
2020-02-14 |
免疫治疗有限公司 |
改良lamp构建物
|
US20200087365A1
(en)
|
2017-05-02 |
2020-03-19 |
Immunomic Therapeutics, Inc |
Improved lamp constructs comprising cancer antigens
|
JP2021523185A
(ja)
|
2018-05-15 |
2021-09-02 |
イミュノミック セラピューティックス, インコーポレイテッドImmunomic Therapeutics, Inc. |
アレルゲンを含む改善されたlamp構築物
|
TW202043256A
(zh)
|
2019-01-10 |
2020-12-01 |
美商健生生物科技公司 |
前列腺新抗原及其用途
|
JP2022551732A
(ja)
|
2019-10-18 |
2022-12-13 |
イミュノミック セラピューティックス, インコーポレイテッド |
がん抗原を含む改良lamp構築物
|
BR112022009598A2
(pt)
|
2019-11-18 |
2022-08-16 |
Janssen Biotech Inc |
Vacinas baseadas em calr e jak2 mutantes e uso dos mesmos
|
US20230035403A1
(en)
|
2020-07-06 |
2023-02-02 |
Janssen Biotech, Inc. |
Method For Determining Responsiveness To Prostate Cancer Treatment
|
US20230029453A1
(en)
|
2020-07-06 |
2023-02-02 |
Janssen Biotech, Inc. |
Prostate Neoantigens And Their Uses
|
EP4175721A1
(de)
|
2020-07-06 |
2023-05-10 |
Janssen Biotech, Inc. |
Prostata-neoantigene und ihre verwendungen
|
CN112237633B
(zh)
*
|
2020-10-22 |
2023-06-27 |
林君玉 |
一种pei/on复合物及其制备方法和用途
|
MX2023006056A
(es)
|
2020-11-25 |
2023-06-06 |
Akagera Medicines Inc |
Nanoparticulas lipidicas para suministro de acidos nucleicos y metodos de uso de las mismas.
|
GB202108176D0
(en)
|
2021-06-08 |
2021-07-21 |
Touchlight Ip Ltd |
Vector
|
AU2022289260A1
(en)
|
2021-06-08 |
2023-12-07 |
Touchlight IP Limited |
Lentiviral vector
|
WO2023201201A1
(en)
|
2022-04-10 |
2023-10-19 |
Immunomic Therapeutics, Inc. |
Bicistronic lamp constructs comprising immune response enhancing genes and methods of use thereof
|